BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 28479091)

  • 41. Nucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminase.
    Nabel CS; Lee JW; Wang LC; Kohli RM
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14225-30. PubMed ID: 23942124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
    Granadillo Rodríguez M; Flath B; Chelico L
    Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of Genomic Alteration from Cytidine Deamination.
    Liu X; Meng FL
    Adv Exp Med Biol; 2018; 1044():49-64. PubMed ID: 29956291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
    Xie K; Sowden MP; Dance GS; Torelli AT; Smith HC; Wedekind JE
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8114-9. PubMed ID: 15148397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. APOBECs orchestrate genomic and epigenomic editing across health and disease.
    Cervantes-Gracia K; Gramalla-Schmitz A; Weischedel J; Chahwan R
    Trends Genet; 2021 Nov; 37(11):1028-1043. PubMed ID: 34353635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation-induced deoxycytidine deaminase: Structural basis for favoring WRC hot motif specificities unique among APOBEC family members.
    Pham P; Afif SA; Shimoda M; Maeda K; Sakaguchi N; Pedersen LC; Goodman MF
    DNA Repair (Amst); 2017 Jun; 54():8-12. PubMed ID: 28388461
    [No Abstract]   [Full Text] [Related]  

  • 47. Crosstalk between genetic and epigenetic information through cytosine deamination.
    Chahwan R; Wontakal SN; Roa S
    Trends Genet; 2010 Oct; 26(10):443-8. PubMed ID: 20800313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical Basis of APOBEC3 Deoxycytidine Deaminase Activity on Diverse DNA Substrates.
    Adolph MB; Love RP; Chelico L
    ACS Infect Dis; 2018 Mar; 4(3):224-238. PubMed ID: 29347817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA.
    Caval V; Jiao W; Berry N; Khalfi P; Pitré E; Thiers V; Vartanian JP; Wain-Hobson S; Suspène R
    BMC Genomics; 2019 Nov; 20(1):858. PubMed ID: 31726973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.
    Niewiadomska AM; Tian C; Tan L; Wang T; Sarkis PT; Yu XF
    J Virol; 2007 Sep; 81(17):9577-83. PubMed ID: 17582006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s.
    Hou S; Lee JM; Myint W; Matsuo H; Kurt Yilmaz N; Schiffer CA
    J Biol Chem; 2021 Aug; 297(2):100909. PubMed ID: 34171358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APOBEC3A damages the cellular genome during DNA replication.
    Green AM; Landry S; Budagyan K; Avgousti DC; Shalhout S; Bhagwat AS; Weitzman MD
    Cell Cycle; 2016; 15(7):998-1008. PubMed ID: 26918916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
    Romani B; Engelbrecht S; Glashoff RH
    Arch Virol; 2009; 154(10):1579-88. PubMed ID: 19669862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
    Gao J; Choudhry H; Cao W
    Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions.
    Prohaska KM; Bennett RP; Salter JD; Smith HC
    Wiley Interdiscip Rev RNA; 2014; 5(4):493-508. PubMed ID: 24664896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
    Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
    Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A.
    Carpenter MA; Li M; Rathore A; Lackey L; Law EK; Land AM; Leonard B; Shandilya SM; Bohn MF; Schiffer CA; Brown WL; Harris RS
    J Biol Chem; 2012 Oct; 287(41):34801-8. PubMed ID: 22896697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The implications of APOBEC3-mediated C-to-U RNA editing for human disease.
    Van Norden M; Falls Z; Mandloi S; Segal BH; Baysal BE; Samudrala R; Elkin PL
    Commun Biol; 2024 May; 7(1):529. PubMed ID: 38704509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Error-free versus mutagenic processing of genomic uracil--relevance to cancer.
    Krokan HE; Sætrom P; Aas PA; Pettersen HS; Kavli B; Slupphaug G
    DNA Repair (Amst); 2014 Jul; 19():38-47. PubMed ID: 24746924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNAs regulate APOBEC gene expression.
    Cao W; Wu W
    Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.